Opinion: Help pharmacists fulfill the goals of 'test to treat'
Washington Post, Jenni Zilka
During the State of the Union address, President Biden announced the “test to treat” initiative to allow patients to get tested for the coronavirus at pharmacies and, if positive, receive oral antiviral pills immediately at no cost [”White House ‘test to treat’ plan garners praise, raises questions,” Politics & the Nation, March 5]. This is an important acknowledgment of pharmacy accessibility and capability, and I commend the administration’s recognition of pharmacy and its value to public health. As we now know, timely testing and treatment are essential to curb the spread and reduce hospitalizations. Though this initiative is a positive step forward, we must address the legislative hurdles that will challenge the long-term viability of the “test to treat” model.
For the full article, click here.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.